Abstract
Two gene-targeting approaches have been developed with the use of RNase P. The first approach is based on an external guide sequence (EGS), which consists of a sequence complementary to a target mRNA and, when noncovalently complexed with RNase P, renders the target RNA susceptible to degradation by the ribonuclease. The second is involved in the generation of a sequence-specific ribozyme, M1GS, by covalently linking the RNase P catalytic subunit M1 RNA with a guide sequence that is complementary to a target mRNA. Both the M1GS ribozyme and EGS technology have been shown to be efficient and specific in cleaving an target mRNA sequence in vitro, and effective in down-regulating the expression of the target mRNA in cultured cells. This chapter summarizes the recent progress using the RNase P-based technology and offers insights into the future of using EGS and M1GS as tools for basic research and as gene-targeting agents for clinical applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alifano P, Rivellini F, Piscitelli C, Arraiano CM, Bruni CB, Carlomagno MS (1994) Ribonuclease E provides substrates for ribonuclease P-dependent processing of a polycistronic mRNA. Genes Dev 8:3021–3031
Altman S, Kirsebom LA (1999) Ribonuclease P. In: Gesteland RF, Cech TR, Atkins JF (eds) The RNA world. Cold Spring Harbor Press, Cold Spring Harbor, pp 351–380
Ares M Jr, Igel AH (1990) Lethal and temperature-sensitive mutations and their suppressors identify an essential structural element in U2 small nuclear RNA. Genes Dev 4:2132–2145
Bai Y, Trang P, Li H, Kim K, Zhou T, Liu F (2008) Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA. Proc Natl Acad Sci U S A 105:10919–10924
Bertrand E, Castanotto D, Zhou C, Carbonnelle C, Lee NS, Good P, Chatterjee S, Grange T, Pictet R, Kohn D, Engelke D, Rossi JJ (1997) The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA 3:75–88
Berzal-Herranz A, Joseph S, Burke JM (1992) In vitro selection of active hairpin ribozymes by sequential RNA-catalyzed cleavage and ligation reactions. Genes Dev 6:129–134
Bothwell AL, Garber RL, Altman S (1976) Nucleotide sequence and in vitro processing of a precursor molecule to Escherichia coli 4.5 S RNA. J Biol Chem 251:7709–7716
Brunel C, Romby P (2000) Probing RNA structure and RNA-ligand complexes with chemical probes. Methods Enzymol 318:3–21
Cobaleda C, Sanchez-Garcia I (2000) In vitro inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment. Blood 95:731–737
Dorsett Y, Tuschl T (2004) siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3:318–329
Doudna JA, Cech TR (2002) The chemical repertoire of natural ribozymes. Nature 418:222–228
Dunn W, Trang P, Khan U, Zhu J, Liu F (2001) RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences. Proc Natl Acad Sci U S A 98:14831–14836
Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822
Evans D, Marquez SM, Pace NR (2006) RNase P: interface of the RNA and protein worlds. Trends Biochem Sci 31:333–341
Forster AC, Altman S (1990) External guide sequences for an RNA enzyme. Science 249:783–786
Frank DN, Harris M, Pace NR (1994) Rational design of self-cleaving pre-tRNA-ribonuclease P RNA conjugates. Biochemistry 33:10800–10808
Frank DN, Pace NR (1998) Ribonuclease P: unity and diversity in a tRNA processing ribozyme. Annu Rev Biochem 67:153–180
Gopalan V, Altman S (2007) Ribonuclease P: structure and catalysis. In: Gesteland RF, Cech TR, Atkins JF (eds) The RNA world. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35:849–857
Guerrier-Takada C, Li Y, Altman S (1995) Artificial regulation of gene expression in Escherichia coli by RNase P. Proc Natl Acad Sci U S A 92:11115–11119
Guerrier-Takada C, Salavati R, Altman S (1997) Phenotypic conversion of drug-resistant bacteria to drug sensitivity. Proc Natl Acad Sci U S A 94:8468–8472
Hannon GJ, Rossi JJ (2004) Unlocking the potential of the human genome with RNA interference. Nature 431:371–378
Hnatyszyn H, Spruill G, Young A, Seivright R, Kraus G (2001) Long-term RNase P-mediated inhibition of HIV-1 replication and pathogenesis. Gene Ther 8:1863–1871
Horster A, Teichmann B, Hormes R, Grimm D, Kleinschmidt J, Sczakiel G (1999) Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy. Gene Ther 6:1231–1238
Hsu AW, Kilani AF, Liou K, Lee J, Liu F (2000) Differential effects of the protein cofactor on the interactions between an RNase P ribozyme and its target mRNA substrate. Nucleic Acids Res 28:3105–3116
Jackson JK, Liang LS, Hunter WL, Reynolds M, Sandberg JA, Springate C, Burt HM (2002) The encapsulation of ribozymes in biodegradable polymeric matrices. Int J Pharm 243:43–55
Joseph S, Berzal-Herranz A, Chowrira BM, Butcher SE, Burke JM (1993) Substrate selection rules for the hairpin ribozyme determined by in vitro selection, mutation, and analysis of mismatched substrates. Genes Dev 7:130–138
Joyce GF (1992) Directed molecular evolution. Sci Am 267:90–97
Kawa D, Wang J, Yuan Y, Liu F (1998) Inhibition of viral gene expression by human ribonuclease P. RNA 4:1397–1406
Kilani AF, Liu F (1999) UV cross-link mapping of the substrate-binding site of an RNase P ribozyme to a target mRNA sequence. RNA 5:1235–1247
Kilani AF, Trang P, Jo S, Hsu A, Kim J, Nepomuceno E, Liou K, Liu F (2000) RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expressionin cell culture. J Biol Chem 275:10611–10622
Kim K, Trang P, Umamoto S, Hai R, Liu F (2004a) RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins. Nucleic Acids Res 32:3427–3434
Kim K, Umamoto S, Trang P, Hai R, Liu F (2004b) Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus. RNA 10:438–447
Kim K, Liu F (2007) Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences. Biochim Biophys Acta 1769:603–612
Ko JH, Izadjoo M, Altman S (2008) Inhibition of expression of virulence genes of Yersinia pestis in Escherichia coli by external guide sequences and RNase P. RNA 14:1656–1662
Komine Y, Kitabatake M, Yokogawa T, Nishikawa K, Inokuchi H (1994) A tRNA-like structure is present in 10Sa RNA, a small stable RNA from Escherichia coli. Proc Natl Acad Sci U S A 91:9223–9227
Kraus G, Geffin R, Spruill G, Young AK, Seivright R, Cardona D, Burzawa J, Hnatyszyn HJ (2002) Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences. Proc Natl Acad Sci U S A 99:3406–3411
Lee NS, Bertrand E, Rossi J (1999) mRNA localization signals can enhance the intracellular effectiveness of hammerhead ribozymes. RNA 5:1200–1209
Li H, Trang P, Kim K, Zhou T, Umamoto S, Liu F (2006) Effective inhibition of human cytomegalovirus gene expression and growth by intracellular expression of external guide sequence RNA. RNA 12:63–72
Liu F, Altman S (1995) Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli. Genes Dev 9:471–480
Liu F, Altman S (1996) Requirements for cleavage by a modified RNase P of a small model substrate. Nucleic Acids Res 24:2690–2696
Lorsch JR, Szostak JW (1994) In vitro evolution of new ribozymes with polynucleotide kinase activity. Nature 371:31–36
Lundblad EW, Xiao G, Ko JH, Altman S (2008) Rapid selection of accessible and cleavable sites in RNA by Escherichia coli RNase P and random external guide sequences. Proc Natl Acad Sci U S A 105:2354–2357
Ma M, Benimetskaya L, Lebedeva I, Dignam J, Takle G, Stein CA (2000) Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. Nat Biotechnol 18:58–61
Ma MY, Jacob-Samuel B, Dignam JC, Pace U, Goldberg AR, George ST (1998) Nuclease-resistant external guide sequence-induced cleavage of target RNA by human ribonuclease P. Antisense Nucleic Acid Drug Dev 8:415–426
Mann H, Ben-Asouli Y, Schein A, Moussa S, Jarrous N (2003) Eukaryotic RNase P: role of RNA and protein subunits of a primordial catalytic ribonucleoprotein in RNA-based catalysis. Mol Cell 12:925–935
Mautino MR (2002) Lentiviral vectors for gene therapy of HIV-1 infection. Curr Gene Ther 2:23–43
McClain WH, Guerrier-Takada C, Altman S (1987) Model substrates for an RNA enzyme. Science 238:527–530
McKinney J, Guerrier-Takada C, Wesolowski D, Altman S (2001) Inhibition of Escherichia coli viability by external guide sequences complementary to two essential genes. Proc Natl Acad Sci U S A 98:6605–6610
McKinney J, Guerrier-Takada C, Galan J, Altman S (2002) Tightly regulated gene expression system in Salmonella enterica serovar Typhimurium. J Bacteriol 184:6056–6059
McKinney JS, Zhang H, Kubori T, Galan JE, Altman S (2004) Disruption of type III secretion in Salmonella enterica serovar Typhimurium by external guide sequences. Nucleic Acids Res 32:848–854
Plehn-Dujowich D, Altman S (1998) Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P. Proc Natl Acad Sci U S A 95:7327–7332
Reddy R, Henning D, Das G, Harless M, Wright D (1987) The capped U6 small nuclear RNA is transcribed by RNA polymerase III. J Biol Chem 262:75–81
Sarver N, Cantin EM, Chang PS, Zaia JA, Ladne PA, Stephens DA, Rossi JJ (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247:1222–1225
Scherer LJ, Rossi JJ (2003) Approaches for the sequence-specific knockdown of mRNA. Nat Biotechnol 21:1457–1465
Sharin E, Schein A, Mann H, Ben-Asouli Y, Jarrous N (2005) RNase P: role of distinct protein cofactors in tRNA substrate recognition and RNA-based catalysis. Nucleic Acids Res 33:5120–5132
Stein CA, Cheng YC (1993) Antisense oligonucleotides as therapeutic agents – is the bullet really magical? Science 261:1004–1012
Sullenger BA, Cech TR (1993) Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science 262:1566–1569
Trang P, Hsu AW, Liu F (1999) Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate. Nucleic Acids Res 27:4590–4597
Trang P, Kilani AF, Kim J, Liu F (2000a) A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1. J Mol Biol 301:817–826
Trang P, Lee M, Nepomuceno E, Kim J, Zhu H, Liu F (2000b) Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. Proc Natl Acad Sci U S A 97:5812–5817
Trang P, Hsu A, Zhou T, Lee J, Kilani AF, Nepomuceno E, Liu F (2002) Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding. J Mol Biol 315:573–586
Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510
Verma S, Eckstein F (1998) Modified oligonucleotides: synthesis and strategy for users. Annu Rev Biochem 67:99–134
Warashina M, Kuwabara T, Kato Y, Sano M, Taira K (2001) RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA. Proc Natl Acad Sci U S A 98:5572–5577
Werner M, Rosa E, Nordstrom JL, Goldberg AR, George ST (1998) Short oligonucleotides as external guide sequences for site-specific cleavage of RNA molecules with human RNase P. RNA 4:847–855
Xiao G, Lundblad EW, Izadjoo M, Altman S (2008) Inhibition of expression in Escherichia coli of a virulence regulator MglB of Francisella tularensis using external guide sequence technology. PLoS ONE 3:e3719
Xiao S, Scott F, Fierke CA, Engelke DR (2002) Eukaryotic ribonuclease P: a plurality of ribonucleoprotein enzymes. Annu Rev Biochem 71:165–189
Yang YH, Li H, Zhou T, Kim K, Liu F (2006) Engineered external guide sequences are highly effective in inducing RNase P for inhibition of gene expression and replication of human cytomegalovirus. Nucleic Acids Res 34:575–583
Yu M, Ojwang J, Yamada O, Hampel A, Rapapport J, Looney D, Wong-Staal F (1993) A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 90:6340–6344
Yu X, Trang P, Shah S, Atanasov I, Kim YH, Bai Y, Zhou ZH, Liu F (2005) Dissecting human cytomegalovirus gene function and capsid maturation by ribozyme targeting and electron cryomicroscopy. Proc Natl Acad Sci U S A 102(20):7103–7108
Yuan Y, Hwang ES, Altman S (1992) Targeted cleavage of mRNA by human RNase P. Proc Natl Acad Sci U S A 89:8006–8010
Yuan Y, Altman S (1994) Selection of guide sequences that direct efficient cleavage of mRNA by human ribonuclease P. Science 263:1269–1273
Zaug AJ, Cech TR (1995) Analysis of the structure of Tetrahymena nuclear RNAs in vivo: telomerase RNA, the self-splicing rRNA intron, and U2 snRNA. RNA 1:363–374
Zhang H, Altman S (2004) Inhibition of the expression of the human RNase P protein subunits Rpp 21, Rpp25, Rpp29 by external guide sequences (EGSs) and siRNA. J Mol Biol 342:1077–1083
Zhou T, Kim J, Kilani AF, Kim K, Dunn W, Jo S, Nepomuceno E, Liu F (2002) In vitro selection of external guide sequences for directing RNase P-mediated inhibition of viral gene expression. J Biol Chem 277:30112–30120
Zhu J, Trang P, Kim K, Zhou T, Deng H, Liu F (2004) Effective inhibition of Rta expression and lytic replication of Kaposi’s sarcoma-associated herpesvirus by human RNase P. Proc Natl Acad Sci U S A 101:9073–9078
Zou H, Lee J, Umamoto S, Kilani AF, Kim J, Trang P, Zhou T, Liu F (2003) Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells. J Biol Chem 278:37265–37274
Zou H, Lee J, Kilani AF, Kim K, Trang P, Kim J, Liu F (2004) Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA. J Biol Chem 279:32063–32070
Zu Putlitz J, Yu Q, Burke JM, Wands JR (1999) Combinatorial screening and intracellular antiviral activity of hairpin ribozymes directed against hepatitis B virus. J Virol 73:5381–5387
Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415
Acknowledgments
I apologize to the many authors whose publications were left unreferenced in this review due to space constraints. Special thanks go to Gerry Abenes, Kihoon Kim, Yong Bai, and Ed Yang for invaluable discussions on the manuscript and for preparations of the illustrations, and Sarah Viducich for editorial assistance. I also acknowledge the National Institutes of Health for their longstanding and generous support of our research on RNase P ribozyme and the EGS technology (AI041927 and DE014842).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Liu, F. (2010). Ribonuclease P as a Tool. In: Liu, F., Altman, S. (eds) Ribonuclease P. Protein Reviews, vol 10. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1142-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1142-1_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1141-4
Online ISBN: 978-1-4419-1142-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)